Nature Reviews Rheumatology
Nature Reviews Rheumatology (commonly abbreviated as Nat. Rev. Rheumatol.) is a rheumatology review journal published by Springer Nature. It was founded in 2005 as Nature Clinical Practice Rheumatology, took its current title in 2009, is issued monthly, carries Reviews, Consensus Statements and Perspectives among its content types, and had an impact factor of 33.7 in 2025.Nature Reviews Rheumatology（常用缩写 Nat. Rev. Rheumatol.）是 Springer Nature 旗下风湿病学领域的综述类期刊，2005 年以 Nature Clinical Practice Rheumatology 之名创刊，2009 年改用现名，按月刊出版，刊载综述、共识声明与观点等体裁，2025 年影响因子为 33.7。[1]
Scope
- Disciplinary focus: the scope of the journal covers the entire spectrum of rheumatology research. The editorial team works to ensure that its articles are accessible to the widest possible audience, offering equally clear entry points for readers coming from different specialties.学科定位： 期刊的选题范围覆盖风湿病学研究的全部谱系；编辑团队力求文章能被尽可能广泛的读者群体读懂，并为不同专科背景的读者提供同样清晰的切入点。
- Subjects covered: the journal covers the prevention, diagnosis and treatment of conditions of the joints, muscle, bones, blood vessels and connective tissues, including systemic autoimmune diseases, inflammatory and degenerative joint diseases, regional musculoskeletal disorders, osteoporosis and other metabolic bone diseases, pain management, imaging, immunology, genetics, clinical trials, epidemiology and clinical outcomes.选题范围： 覆盖关节、肌肉、骨、血管与结缔组织疾病的预防、诊断与治疗，涉及系统性自身免疫病、炎症性与退行性关节病、局限性肌肉骨骼疾病、骨质疏松及其他代谢性骨病、疼痛管理、影像学、免疫学、遗传学、临床试验、流行病学与临床结局。
- Specific conditions: individual conditions covered include rheumatoid arthritis and osteoarthritis, systemic lupus erythematosus and lupus nephritis, bone disease and bone biology, systemic sclerosis and Raynaud phenomenon, antiphospholipid syndrome, Sjögren syndrome, spondyloarthritis, gout and other crystal deposition diseases, autoinflammatory diseases, the idiopathic inflammatory myopathies, fibromyalgia and vasculitis, with paediatric rheumatology treated as a distinct area.疾病清单： 具体病种包括类风湿关节炎与骨关节炎、系统性红斑狼疮与狼疮性肾炎、骨病与骨生物学、系统性硬化症与雷诺现象、抗磷脂综合征、干燥综合征、脊柱关节炎、痛风与晶体沉积病、自身炎症性疾病、特发性炎性肌病、纤维肌痛与血管炎等，并单列儿科风湿病学方向。
- Content types and commissioning: in-depth Reviews present authoritative and up-to-date information on a topic and place it in the context of the history and development of the field, Consensus Statements provide evidence-based or eminence-based recommendations and present a balanced view, and Perspectives, Comment and News & Views articles proffer topical discussion and opinion. Articles can only be published using the subscription route, the publisher offers no immediate gold open access option and charges no publication fee.体裁与约稿： 深度综述提供权威且与时更新的信息，并把选题放进该领域的历史与发展的脉络中加以定位，共识声明给出以证据或专家共识为基础的平衡建议，观点与评论文章则提供时事性讨论；文章只能按订阅方式出版，出版方不提供立即开放获取选项，也不收取版面费。
- Commissioned model: Reviews and Perspectives are written by external authors invited or commissioned by the in-house editors. Authors may submit proposals for Review-type and Comment-type articles through the online submission system, and these are considered, but the great majority of published content is commissioned.约稿模型： 综述与观点文章由编辑部邀请或约请领域内的学者撰写，作者可在在线投稿系统中提交综述类与评论类的选题提案，编辑部会考虑这些提案，但刊载内容以约稿为绝对主体。
History
- 2005: the journal was launched as Nature Clinical Practice Rheumatology, one of the Nature Clinical Practice clinical titles that Nature Publishing Group issued in 2004 and 2005, a series endorsed at the time by prestigious societies and organizations including the Asia Pacific League of Associations for Rheumatology and the American College of Gastroenterology.2005年： 期刊以 Nature Clinical Practice Rheumatology 之名创刊，是自然出版集团在 2004 年与 2005 年推出的 Nature Clinical Practice 临床系列刊物之一，该系列当时由包括亚太风湿病学会联盟与美国胃肠病学院在内的多个权威学会与组织背书。
- 2009: the publisher rebranded eight clinical journals under the Nature Reviews name, taking the series from seven titles to fifteen, and this title became Nature Reviews Rheumatology. The changes included a move to full-colour printing and a website redesign, with each issue thereafter carrying about a quarter more content than before.2009年： 出版方把八本临床类刊物统一改冠 Nature Reviews 品牌，系列规模由七本扩至十五本，本刊自此定名为 Nature Reviews Rheumatology；改版内容包括转为全彩印刷与网站重新设计，每期内容比原先增加约四分之一。
- Editorial arrangements: at the time of the rebranding the publisher stated that the clinical journals would not change their editorial scopes or commissioning strategies and would retain their distinguished external Editors-in-Chief and international Advisory Boards. This journal has kept that arrangement and still has an external Advisory Board of internationally renowned rheumatologists providing advice and support.编委安排： 出版方在改版时声明这批临床刊物不改变选题范围与约稿策略，并保留原有的外聘主编与国际顾问委员会，本刊沿用这一安排，至今仍设有一支由国际知名风湿病学家组成的外部顾问委员会提供建议与支持。
- Publisher: Nature Publishing Group was first a publishing division of Macmillan, and in 2015 it merged with the Springer Science and Business Media Group. The title is now published under the Springer Nature name, a group whose main offices are in London, with further offices in New York and Tokyo.出版方： 自然出版集团先为麦克米伦旗下的出版部门，后于 2015 年与施普林格科学与商业出版集团合并，今日以 Springer Nature 名义出版，集团主要办公室设在伦敦，并在纽约与东京另设办公室。
- The 2020s: the impact factor peaked at 32.286 in 2021, eased back as the field fluctuated overall to stand at 32.7 in 2024, and recovered to 33.7 in 2025, keeping the journal among the most highly ranked titles in rheumatology by impact factor.2020年代： 期刊影响因子在 2021 年达到 32.286 的高点，其后随领域整体波动回落，2024 年为 32.7，2025 年回升至 33.7，长期稳居风湿病学类期刊影响因子排序前列。[2]
Editors
- Chief Editor: the journal is led by Sarah Onuora, who gained an honours BSc in biology at McMaster University in Canada. Her career in publishing began in 2005 in the editorial office of Rheumatology, a research journal published by the British Society for Rheumatology. She joined the Nature Reviews series in 2007 as an Assistant Editor on Nature Reviews Neurology before moving to this title, where she served as Associate Editor and then Senior Editor, and has been Chief Editor since December 2015 from the London office.主编： 现任主编为 Sarah Onuora，她在加拿大麦克马斯特大学取得生物学荣誉学士学位，2005 年以出版业起步于英国风湿病学会旗下研究期刊 Rheumatology 的编辑部，2007 年加入自然评论系列并先在 Nature Reviews Neurology 任助理编辑，随后转入本刊，历任副编辑与高级编辑，2015 年 12 月出任主编，常驻伦敦办公室。
- Senior Editor: Jessica McHugh PhD serves as Senior Editor. She graduated with a first-class BSc in biomedical science from Durham University in 2010 and began a PhD at the University of Cambridge, studying the role of post-transcriptional regulators in CD4 T cell activation. Moving from the lab into science publishing, she joined this journal in October 2016 and was promoted to Senior Editor in 2019.高级编辑： Jessica McHugh 博士担任高级编辑，她于 2010 年在杜伦大学以生物医学科学一等学士毕业，随后在剑桥大学攻读博士学位，研究转录后调控因子在辅助性 T 细胞活化中的作用；离开实验室后进入科学出版业，2016 年 10 月加入本刊并于 2019 年升任高级编辑。
- Associate Editor: Holly Webster PhD serves as Associate Editor. She took a first-class honours degree in immunology from the University of Glasgow in 2017 and completed her PhD in 2021 on immune competition and cytokine signalling in helminth infection, then carried out postdoctoral research at Glasgow and at Imperial College London. Her interest in rheumatology developed from collaborating with rheumatologists in both cities, and she joined the journal in July 2024.副编辑： Holly Webster 博士担任副编辑，她于 2017 年在格拉斯哥大学以免疫学一等荣誉学位毕业，2021 年完成关于蠕虫感染中免疫竞争与细胞因子信号的研究而获博士学位，此后先在格拉斯哥与帝国理工学院从事博士后研究，其对风湿病学的兴趣来自与两地风湿病专家的密切协作，2024 年 7 月加入本刊。
- Advisory board: the external Advisory Board is made up of renowned rheumatologists based across a wide range of countries, with members affiliated with institutions in Nigeria, India, Germany, France, Singapore, Sweden, Denmark, the Netherlands, Spain, South Korea, the United States, Canada, Australia, Brazil, Turkey, the Philippines and China. The editorial team of the journal itself is based in London.顾问委员会： 外部顾问委员会由来自多国的知名风湿病学家组成，成员所在机构分布于尼日利亚、印度、德国、法国、新加坡、瑞典、丹麦、荷兰、西班牙、韩国、美国、加拿大、澳大利亚、巴西、土耳其、菲律宾与中国等地，刊物本身与本刊编辑团队均常驻伦敦。
- Submissions and contact: manuscripts and proposals are submitted through the Nature Publishing Group online submission and tracking system, where a proposal requires only a single article file. General editorial inquiries and status queries go to the journal's editorial office email address.投稿与联系： 稿件与选题提案通过自然出版集团的在线投稿与追踪系统提交，提交提案时只需上传一份文章文件，一般编辑问询与稿件状态查询可发信至期刊的编辑部邮箱。[3]